TGTX - TG Therapeutics Inc Market Cap to Sales Volume

Brandmark of TG Therapeutics Inc (TGTX)

Compliance with environmental waste disposal regulations at TG Therapeutics, Inc. (TGTX) laboratories correlates with price action. The company's industry-average P/S reflects a market valuation where the 10.60 metric indicates its value status. Revenue growth is based on the sale of treatments for multiple sclerosis and B-cell tumors. The primary drivers are the launch of Briumvi, the expansion of therapy, and the potential for mergers within the biotech sector.

tgtherapeutics.com (TGTX) Market Cap to Revenue: for the period 07/04/2022 - 11/17/2026

Analytical breakdowns for TG Therapeutics, Inc. (TGTX)

- stock price and consensus target price:
- market capitalization statistics:
General company analysis:TGTX - TG Therapeutics Inc
Brand item of TG Pharma

For TG Therapeutics, Inc. (TGTX), which develops oncology drugs using AI and automation, the price/sales ratio trend reflects the market's valuation of future sales potential. This metric is calculated as the ratio of market capitalization to total revenue, allowing investors to determine the premium paid for the business amid prolonged clinical trials, where actual income is limited by strict medical oversight.